49762929 - pile of blue pills, closeup
Mumbai, February 03, 2018: Pharma Major, Dr.Reddy’s Laboratories has launched Tetrabenazine Tablets, a therapeutic equivalent generic version of Xenazine (tetrabenazine) in the United States market approved by the US Food and Drug Administration (USFDA).
The Xenazine brand and generic had US sales of around USD322 million MAT for the most recent twelve months ending in November 2017 according to IMS Health.
The company’s Tetrabenazine Tablets are available in strengths of 12.
5 mg and 25 mg, each strength is available in a bottle count size of 112.
United News of India
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…